ClinicalThought

Share

Program Content

Activities

  • FAQs: Aggressive B-Cell
    FAQs: Optimal Selection and Sequencing of Treatment for Patients With Aggressive B-Cell Lymphomas
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2023

    Expires: January 30, 2024

Faculty

cover img faculity

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology & Medical Oncology
Weill Cornell Medicine
New York, New York

cover img faculity

John P. Leonard, MD

Senior Associate Dean for Innovation and initiatives
Chair (Interim), Weill Department of Medicine
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/NewYork-Presbyterian
New York, New York

cover img faculity

Laurie H. Sehn, MD, MPH

Chair, Lymphoma Tumour Group
BC Cancer
Vancouver, Canada

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genmab US Inc and AbbVie

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.